An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.
Clinical trial NCT04660812 · COMPLETED
Trial details
- NCT number
- NCT04660812
- Sponsor
- Arcus Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-10
- Primary completion
- 2025-09-05
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.